TipRanks
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market
VSBC
VitaSpring Biomedical
RESEARCH TOOLSreports

VitaSpring Biomedical (VSBC) Income Statement

4 Followers

VitaSpring Biomedical Income Statement

Last quarter (Q2 2027), VitaSpring Biomedical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, VitaSpring Biomedical's net income was $-155.82K. See VitaSpring Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jan 26Jan 23Jan 22Jan 21Jan 20
Total Revenue
$ 0.00$ 0.00$ 5.61M$ 248.20K$ 15.14K
Gross Profit
$ -9.96K$ -219.34K$ 2.07M$ 112.20K$ 1.70K
Operating Expenses
$ 375.46K$ 3.96M$ 584.53K$ 536.91K$ 21.18K
Depreciation and Amortization
$ 9.96K$ 219.34K$ 8.36K$ 450.00$ 450.00
EBITDA
$ -375.45K$ -3.95M$ 1.49M$ -424.26K$ -19.04K
Operating Income
$ -385.41K$ -4.18M$ 1.48M$ -425.38K$ -19.49K
Other Income/Expenses
$ 0.00$ 8.06K$ -2.36K$ -670.00$ 0.00
Pretax Income
$ -385.41K$ -4.17M$ 1.48M$ -425.38K$ 6.92K
Net Income
$ -415.37K$ -4.16M$ 1.26M$ -425.38K$ 6.92K
Per Share Metrics
Basic EPS
$ >-0.01$ -0.02$ <0.01$ >-0.01$ <0.01
Diluted EPS
$ >-0.01$ -0.02$ <0.01$ >-0.01$ <0.01
Weighted Average Shares Outstanding
 207.03M 206.52M 205.98M 91.09M 54.51M
Weighted Average Shares Outstanding (Diluted)
 207.03M 206.52M 205.98M 91.09M 54.51M
Currency in USD

VitaSpring Biomedical Earnings and Revenue History